Genetic Relationship between Schizophrenia and Nicotine Dependence

Sci Rep. 2016 May 10:6:25671. doi: 10.1038/srep25671.

Abstract

It is well known that most schizophrenia patients smoke cigarettes. There are different hypotheses postulating the underlying mechanisms of this comorbidity. We used summary statistics from large meta-analyses of plasma cotinine concentration (COT), Fagerström test for nicotine dependence (FTND) and schizophrenia to examine the genetic relationship between these traits. We found that schizophrenia risk scores calculated at P-value thresholds of 5 × 10(-3) and larger predicted FTND and cigarettes smoked per day (CPD), suggesting that genes most significantly associated with schizophrenia were not associated with FTND/CPD, consistent with the self-medication hypothesis. The COT risk scores predicted schizophrenia diagnosis at P-values of 5 × 10(-3) and smaller, implying that genes most significantly associated with COT were associated with schizophrenia. These results implicated that schizophrenia and FTND/CPD/COT shared some genetic liability. Based on this shared liability, we identified multiple long non-coding RNAs and RNA binding protein genes (DA376252, BX089737, LOC101927273, LINC01029, LOC101928622, HY157071, DA902558, RBFOX1 and TINCR), protein modification genes (MANBA, UBE2D3, and RANGAP1) and energy production genes (XYLB, MTRF1 and ENOX1) that were associated with both conditions. Further analyses revealed that these shared genes were enriched in calcium signaling, long-term potentiation and neuroactive ligand-receptor interaction pathways that played a critical role in cognitive functions and neuronal plasticity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cotinine / blood*
  • Female
  • Gene Regulatory Networks / genetics
  • Genome-Wide Association Study / methods
  • Genome-Wide Association Study / statistics & numerical data
  • Humans
  • Male
  • Polymorphism, Single Nucleotide
  • Risk Assessment / methods*
  • Risk Factors
  • Schizophrenia / blood
  • Schizophrenia / genetics*
  • Signal Transduction / genetics
  • Tobacco Use Disorder / blood
  • Tobacco Use Disorder / genetics*

Substances

  • Cotinine